Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Roudijk

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Health and Quality of Life Outcomes|July 14, 2025
An Australian Value Set for the EQ-5D-Y-3LTianxin Pan, Bram Roudijk, Nancy Devlin, et al.
Pharmacoeconomics|November 1, 2022
An EQ-5D-Y-3L Value Set for BelgiumSarah Dewilde, Bram Roudijk, Nafthali H Tollenaar, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 28, 2026
Exploring Perceived Interactions between EQ-5D-5L and Bolt-ons Using Composite Time-Tradeoff Valuations: A Qualitative StudyStevanus Pangestu, Fanni Rencz, Bram Roudijk, et al.
Social Science & Medicine (1982)|November 5, 2021
An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administrationAureliano Paolo Finch, Michela Meregaglia, Oriana Ciani, et al.
Health and Quality of Life Outcomes|November 28, 2024
EQ-5D-5L population norms and health inequality for Trinidad and Tobago in 2022-2023 and comparison with 2012Henry Bailey, Marcel F Jonker, Eleanor Pullenayegum, et al.
Health and Quality of Life Outcomes|July 3, 2024
The EQ-5D-5L valuation study for Trinidad and TobagoHenry Bailey, Marcel F Jonker, Eleanor Pullenayegum, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2025
The effect of perspective, duration, and views on death on the valuation of severe health statesZhongyu Lang, Stefan A Lipman, Bram Roudijk, et al.
Pharmacoeconomics - Open|September 13, 2023
The EQ-5D-3L Valuation Study in PakistanMadeeha Malik, Ning Yan Gu, Azhar Hussain, et al.
Pharmacoeconomics|November 26, 2022
The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons LearnedSahar Al Shabasy, Bram Roudijk, Maggie Abbassi, et al.
Pharmacoeconomics|November 17, 2021
The EQ-5D-5L Valuation Study in EgyptSahar Al Shabasy, Maggie Abbassi, Aureliano Finch, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Health and Quality of Life Outcomes|July 14, 2025
An Australian Value Set for the EQ-5D-Y-3LTianxin Pan, Bram Roudijk, Nancy Devlin, et al.
Pharmacoeconomics|November 1, 2022
An EQ-5D-Y-3L Value Set for BelgiumSarah Dewilde, Bram Roudijk, Nafthali H Tollenaar, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 28, 2026
Exploring Perceived Interactions between EQ-5D-5L and Bolt-ons Using Composite Time-Tradeoff Valuations: A Qualitative StudyStevanus Pangestu, Fanni Rencz, Bram Roudijk, et al.
Social Science & Medicine (1982)|November 5, 2021
An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administrationAureliano Paolo Finch, Michela Meregaglia, Oriana Ciani, et al.
Health and Quality of Life Outcomes|November 28, 2024
EQ-5D-5L population norms and health inequality for Trinidad and Tobago in 2022-2023 and comparison with 2012Henry Bailey, Marcel F Jonker, Eleanor Pullenayegum, et al.
Health and Quality of Life Outcomes|July 3, 2024
The EQ-5D-5L valuation study for Trinidad and TobagoHenry Bailey, Marcel F Jonker, Eleanor Pullenayegum, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2025
The effect of perspective, duration, and views on death on the valuation of severe health statesZhongyu Lang, Stefan A Lipman, Bram Roudijk, et al.
Pharmacoeconomics - Open|September 13, 2023
The EQ-5D-3L Valuation Study in PakistanMadeeha Malik, Ning Yan Gu, Azhar Hussain, et al.
Pharmacoeconomics|November 26, 2022
The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons LearnedSahar Al Shabasy, Bram Roudijk, Maggie Abbassi, et al.
Pharmacoeconomics|November 17, 2021
The EQ-5D-5L Valuation Study in EgyptSahar Al Shabasy, Maggie Abbassi, Aureliano Finch, et al.
Pageof 5